NOV 16, 2016 8:00 AM PST

The important role of lncRNAs in breast cancer

Sponsored by: Affymetrix, Affymetrix
Speakers

Abstract
DATE:  November 16, 2016
TIME:  8:00am PT, 11:00am ET 

Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among women. Hundreds of thousands of women die each year worldwide, and it is estimated that one in eight US women will develop invasive breast cancer in her lifetime.
 
The heterogeneity of breast cancer with its unique subtypes and genetic mutation profiles makes developing biomarkers and targeted therapies especially important. In addition, the current standard-of-care for most breast cancers is an aggressive course of therapy to prevent progression and metastasis. This course of treatment, however, is far from optimal and considerable overtreatment is known to occur. Thus, it is critically important to identify the underlying mechanisms that drive breast cancer progression and to find novel biomarkers for early detection, prognosis, prediction of treatment response, and to better inform patient treatment options.
 
Long considered to be genomic “junk,” long non-coding RNAs (lncRNAs) have recently gained widespread attention as critical regulators of coding RNA and alternative splicing, and their dysregulation has been associated with tumorigenesis, tumor progression, and metastasis. With only very recent focus, lncRNAs represent a vast source of largely unstudied potential molecular drivers of human cancer, emerging as a new class of promising cancer biomarkers and therapeutic agents.
 
During this webinar, our speakers will:
  • Demonstrate how novel transcriptome profiling arrays can reliably identify lncRNAs and lead to the discovery of novel cancer biomarkers
  • Explain the importance of better understanding the role of lncRNAs in breast cancer progression and tumorigenesis
  • Answer your questions live during the broadcast!

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 17, 2022 10:00 AM PDT
AUG 17, 2022 10:00 AM PDT
DATE: August 17, 2022 TIME: 10:00am PDT, 1:00pm EDT Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
Loading Comments...
Show Resources